reviewJAMAJan 22, 2019Closed access

Breast Cancer Treatment

Dana-Farber Cancer Institute · Harvard University

PubMed
Indexed incrossrefpubmed

Abstract

IMPORTANCE: Breast cancer will be diagnosed in 12% of women in the United States over the course of their lifetimes and more than 250 000 new cases of breast cancer were diagnosed in the United States in 2017. This review focuses on current approaches and evolving strategies for local and systemic therapy of breast cancer. OBSERVATIONS: Breast cancer is categorized into 3 major subtypes based on the presence or absence of molecular markers for estrogen or progesterone receptors and human epidermal growth factor 2 (ERBB2; formerly HER2): hormone receptor positive/ERBB2 negative (70% of patients), ERBB2 positive (15%-20%), and triple-negative (tumors lacking all 3 standard molecular markers; 15%). More than 90%…

Citation impact

4,811
total citations
FWCI
157.55
Percentile
100%
References
97
Citations per year

Authors

2

Topics & keywords

Keywords
  • Medicine
  • Breast cancer
  • Lumpectomy
  • Oncology
  • Cancer
  • Triple-negative breast cancer
  • Internal medicine
  • Estrogen receptor
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.